| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 06/24/2009 | CN100502821C Application of hydrogel plaster composition in preparing local formulation and the pharmaceutical kits |
| 06/23/2009 | US7550607 Stereoselective Ring Closure olefin Metathesis (RCM) reaction and Enzymatic Resolution (ER) for the production of optically pure synthetic intermediates during an organic synthesis; provides 3,6-dihydro-2H-pyrans |
| 06/23/2009 | US7550590 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 06/23/2009 | US7550510 Reacting hexachloroacetone with solvent-suspended resin-bound triphenylphosphine, chlorinating retinoic acid to provide retinoyl chloride, then stirring in pyridine; chromatography; for induction of apoptosis in cancer cells |
| 06/23/2009 | US7550501 Compounds and methods for treating toll-like receptor 2-related diseases and conditions |
| 06/23/2009 | US7550496 Hypoxia-activated prodrugs of alkylating agents such as of cyclophosphamide, ifosfamide, melphalan, chlorambucil, thiotepa; protected with 2-nitroimidazolyl group; targeted cancer cells more effectively, side effect reduction |
| 06/23/2009 | US7550490 Cancer and psoriasis; e.g. N-(2-amino-4-fluorophenyl)-4-[N-(Pyridin-3-ylacryloyl)aminomethyl]benzamide |
| 06/23/2009 | US7550484 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine |
| 06/23/2009 | US7550480 1,8-naphthyridin-2(1H)-ones; treating CSBP/p38 kinase mediated diseases; cytokine suppressive anti-inflammatory drugs |
| 06/23/2009 | US7550450 Prostate cancer treatment |
| 06/23/2009 | US7550441 Controlled release polymer nanoparticle containing bound nucleic acid ligand for targeting |
| 06/23/2009 | US7550283 Bacteriophage for lysis of Methylobacterium and compositions and uses thereof |
| 06/23/2009 | CA2459400C Plaster for the treatment of dysfunctions and disorders of nails |
| 06/23/2009 | CA2449874C New indole derivatives with 5-ht6 receptor affinity |
| 06/23/2009 | CA2362728C Improved aqueous solubility pharmaceutical formulations |
| 06/18/2009 | WO2004024077A3 Novel composition and methods for the treatment of psoriasis |
| 06/18/2009 | US20090156681 Compounds for the treatment of metabolic disorders |
| 06/18/2009 | US20090156567 Novel anti-inflammatory androstane derivative |
| 06/18/2009 | US20090156513 freeze-dried fruit pulp powder; antioxidants comprises a high concentration of anthocyanin; treating disease or injury and damage induced by pathological free radicals; has a cyclooxygenase inhibition value greater than Aspirin; anticarcinogenic, antiinflammatory, antiarthritic agents; aging resistance |
| 06/18/2009 | US20090156507 Cell permeable conjugates of peptides for inhibition of protein kinases |
| 06/18/2009 | US20090155398 Jucara and acai fruit-based dietary supplements |
| 06/18/2009 | US20090155264 Novel composition and methods for the treatment of psoriasis |
| 06/18/2009 | US20090155263 Compositions and methods for the treatment of immune related diseases |
| 06/18/2009 | US20090155257 Immunoglobulin variants and uses thereof |
| 06/18/2009 | US20090155235 Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 06/18/2009 | US20090155203 Thrombopoietin mimetics |
| 06/18/2009 | US20090155201 Alkylated poly(allylamine) polymers and methods of use |
| 06/18/2009 | US20090153071 Ignition circuit for igniting a discharge lamp and method for igniting the discharge Lamp |
| 06/17/2009 | EP2070551A1 Improved thickened beverages for dysphagia |
| 06/17/2009 | EP1633323B1 Ternary eutectic mixtures of local anesthetics |
| 06/17/2009 | EP1390378B1 Pharmaceutically active uridine esters |
| 06/17/2009 | CN100500651C Crystalline and pure modafinil and process of preparing the same |
| 06/17/2009 | CN100500209C CLK-peptide and SLK-peptide |
| 06/17/2009 | CN100500172C A novel polyherbal preparation for the prevention of atherosclerosis and hyperlipidemia |
| 06/17/2009 | CN100500146C Application of Vinpocetine and its derivant for treatment and prophylaxis of epilepsy and its complication |
| 06/16/2009 | US7547779 Preparation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
| 06/16/2009 | US7547444 Methods for controlling fungi and bacteria |
| 06/16/2009 | CA2452217C Hiv inhibiting pyrimidines derivatives |
| 06/16/2009 | CA2381097C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 06/16/2009 | CA2284802C Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 06/11/2009 | WO2004069199A8 Marketing system for improving patient compliance and methods and devices relating to same |
| 06/11/2009 | WO2003051280A3 Intraoral discluder device and method for preventing migraine and tension headaches and temporomandibular disorders |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149500 solid forms of lenalidomide, treating cancer, inflammatory disease, myelodysplastic syndrome, undesired angiogenesis |
| 06/11/2009 | US20090149499 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione) |
| 06/11/2009 | US20090149459 P38 inhibitors and methods of use thereof |
| 06/11/2009 | US20090149379 Novel use of cytokine inhibitors |
| 06/11/2009 | US20090148888 Recombinant toxin fragments |
| 06/11/2009 | US20090148829 Methods For Rapid Identification Of Pathogens In Humans And Animals |
| 06/11/2009 | US20090148517 Melt-extrusion multiparticulates |
| 06/11/2009 | US20090148509 Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles |
| 06/11/2009 | US20090148468 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 06/11/2009 | US20090148444 Pharmaceutical composition for treating immune diseases |
| 06/11/2009 | US20090148431 Modulating the production of neurons and/or oligodendrocytes from white matter progenitor cells |
| 06/11/2009 | US20090148403 Interleukin-9 Antagonist Muteins and Their Pharmacological Methods of Use |
| 06/11/2009 | US20090148390 Jucara and acai fruit-based dietary supplements |
| 06/10/2009 | EP2068147A1 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 06/10/2009 | CN100497386C Antibodies of non-functional P2X7 receptor and its uses |
| 06/10/2009 | CN100497340C Condensed purine derivatives as A1 adenosine receptor antagonists |
| 06/10/2009 | CN100496607C Combination of a NSAID and a PDE-4 inhibitor |
| 06/10/2009 | CN100496244C Nodulisporic acid derivative spot-on formulations for killing parasites |
| 06/09/2009 | US7544822 Recovery of phytonutrients from oils |
| 06/09/2009 | US7544777 Porphorymonas gingivalis polypeptides and nucleotides |
| 06/09/2009 | US7544713 Compounds and methods for delivery of prostacyclin analogs |
| 06/09/2009 | US7544708 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 06/09/2009 | US7544510 Stem cells of the islets of Langerhans and their use in treating diabetes mellitus |
| 06/09/2009 | CA2343923C Reactive nanoparticles as destructive adsorbents for biological and chemical contamination |
| 06/09/2009 | CA2261706C The use of growth factor modulating compounds |
| 06/09/2009 | CA2251355C Il-6 mutein |
| 06/04/2009 | US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof |
| 06/04/2009 | US20090143422 P38 inhibitors and methods of use thereof |
| 06/04/2009 | US20090143389 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2009 | US20090143382 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 06/04/2009 | US20090142850 test film made of water soluble two polymers, one having high molecular weight and the other having low molecular weight such as hydroxypropyl cellulose, hydroxymethyl propyl cellulose; for detecting chorionic gonadotropin, glucose, prostate specific antigen, metabolites; pesticides; or toxin; monolayer |
| 06/04/2009 | US20090142315 Methods for the Dietary Management of Irritable Bowel Syndrome and Carbohydrate Malabsorption |
| 06/03/2009 | EP1267840B1 Granulated particles with masked taste |
| 06/03/2009 | EP1165553B1 C10 ester substituted taxanes as antitumor agents |
| 06/03/2009 | CN101445555A Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/03/2009 | CN101445463A Beta2-adrenergic receptor agonists |
| 06/03/2009 | CN101444511A Low dose entecavir formulation and use |
| 06/02/2009 | US7541364 Compounds of the above formula are useful as analgesics for treating pain; as immunomodulators, to modulate the behavioral effects of drugs of abuse and to modulate the development of tolerance and dependence of mu agonists. |
| 06/02/2009 | US7541346 Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs |
| 06/02/2009 | US7541344 Modulation of survivin expression |
| 06/02/2009 | CA2516433C Ramosetron hydrochloride for diarrhea-predominant irritable bowel syndrome |
| 05/28/2009 | WO2005016238A3 Severe acute respiratory syndrome |
| 05/28/2009 | US20090137926 Apparatus and Methods for Repetitive Microjet Drug Delivery |
| 05/28/2009 | US20090137679 ZN2+Chelating Motif-Tethered Short-Chain Fatty Acids as a Novel Class of Histone Deacetylase Inhibitors |
| 05/28/2009 | US20090137664 Saururus cernuus compounds that inhibit cellular responses to hypoxia |
| 05/28/2009 | US20090137643 Methods for Inhibiting or Reversing Tau Filament Fibrillization |
| 05/28/2009 | US20090137639 Methods for controlling fungi and bacteria |
| 05/28/2009 | US20090137633 Stable pharmaceutical composition of rabeprazole |
| 05/28/2009 | US20090137570 Inhibitors of cathepsin s |
| 05/28/2009 | US20090137555 activity of CDK1, CDK2, CDK4, CDK5, GSK3 beta , Bcr-ab1, Flt-3, c-Kit, PDGFR beta , Src, Mek1 and CK1; 2-[N'-(2,3-dibromo-8-oxo-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-c]azepin-4-ylidene)-hydrazino]-benzoic acid; antiinflammatory agent; autoimmune, neurological, cardiovasculal, hormone-related diseases |
| 05/28/2009 | US20090137021 Anti-inflammatory medicaments |
| 05/28/2009 | US20090136596 P38 inhibitors and methods of use thereof |
| 05/28/2009 | US20090136575 Protein Formulation |
| 05/28/2009 | US20090136557 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 05/28/2009 | US20090136519 Tissue Protective Cytokine Receptor Complex, Assays for Identifying Tissue Protective Compounds and Uses Thereof |
| 05/28/2009 | US20090136501 Compositions and methods for treating coagulation related disorders |
| 05/28/2009 | US20090136454 Anti-inflammatory activity from lactic acid bacteria |